Every SEC Form 3/4/5 on record for this filer (CIK 1916987) — 2 issuers, 8 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings, Inc. | Director | 2025-03-28 → 2026-06-05 | 4 | −$60,020 |
| VRNA | Verona Pharma plc | Director | 2022-03-16 → 2025-10-08 | 7 | −$10,827 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| XERS | 2026-03-30 | Sell | 10,834 | $5.54 | $60,020 | 89,166 |
| VRNA | 2025-08-01 | Sell | 824 | $13.14 | $10,827 | 23,176 |
1 of 2 issuers are covered and open a security page; the rest are on file here only.